Acne

  • Statewide referral criteria have been developed for this condition. For more information, please see the Department of Health :Acne

    Introduction

    This guideline relates to acne in paediatric patients. Acne is a condition of psychological and medical significance which is treatable. This guideline is to assist GPs to manage their patients in a primary care setting until clinical thresholds indicate that tertiary care is required. The Royal Children's Hospital (RCH) Acne Clinic aims to provide dermatology care for teenagers with severe acne who are otherwise unable to access private dermatologist care.

    When to refer

    • Patients <18 years of age
    • Evidence of nodular/cystic or scarring acne
    • Appropriate skin care measures, including prescription topical treatments, have not been effective
    • Patients with pustular acne who have failed 3 months of oral antibiotics
    • Patients for who the acne is causing significant mental health issues or concerns

    Wait time for appointments 

    Specialist Clinic wait times 

    Services available closer to home

    There is no restriction on location, therefore referrals are accepted from throughout Victoria. Face to face appointments are preferred. Tele-health will be considered based on individual circumstances.

    Referral criteria/required information

    Statewide referral criteria must be met: Acne

    • Treatment to date
    • Impact of symptoms
    • History of presenting complaint, associated symptoms and risk factors

    How to refer

    Specialist Clinics referral

    Please complete the above and submit via:

    • Facsimile (03) 9345 5034 or
    • Email screferrals@rch.org.au
    • Urgent referral or clinical query call ED or Registrar on-call (03) 9345 5522

    Suggested pre-referral management

    • Address potential triggers which may include the following; Diet i.e. > 500ml low fat milk per day; high GI; whey protein supplements or shakes; Not washing out hair product; Changing the pillow case less than once a week; Not showering after sweating; Squeezing or picking the skin; Not removing make up
    • Implement general skin care measures. Wash the affected area with soap free wash morning and night i.e. QV Gentle Wash, CeraVe Hydrating Cleanser. Consider adding a salicylic acid cleanser twice a week if the skin is not improving i.e. La Roche Posay Effaclar Micro Peeling Purifying Gel Cleanser, CeraVe Blemish Control Cleanser. Avoid oil based or occlusive products. Minimise actives and reduce the number of products used
    • Commence topical treatment as appropriate i.e. topical retinoid, benzyl peroxide, clindamycin or a combination product
    • Consider hormonal therapy for females with acne and other problems around menstruation i.e. Yasmin, Yaz, Dianne/Brenda/Estelle
    • If failed 8 weeks of topical treatment, commence oral treatment i.e. Doxycycline 50mg- 100mg mane (8 years +); Erythromycin BD (< 8 years age)
    • Assess how much acne is affecting mental health and self-esteem – may require more urgent referral to dermatology or a mental health provider

    Information for families

    • Start prescription topical treatments slowly. Apply to commonly affected areas two nights per week, increasing to every night as tolerated. Wash off in the morning. If the skin becomes dry or irritated, decrease the frequency of application
    • Apply to completely dry skin. When applying topical medications use the 5 dot method - place a small pea size amount of the medication in each of the 5 locations on the face: mid forehead, each cheek, nose and chin. The medication should be rubbed into the entire area
    • After 30 minutes, apply a moisturising lotion or cream over the top of the prescription cream i.e. CeraVe Lotion, Cetaphil Lotion, QV Lotion or if very dry QV Cream, CeraVe Cream, La Roche Posay Lipikar AP+M

    Prescription topical and oral treatments may cause increased sensitivity to the sun. Always apply a non- greasy light sunscreen to exposed areas i.e. La Roche Posay Anthelios 50+, Ego SunSense Ultra 50+, Neutrogena Ultra Sheer Fluid Sunscreen 50+.

    Resources and links

    Acknowledgements

    The development of this guideline was coordinated by the Department of Dermatology. Guideline reviewed in February 2025.